Citrobacter freundii phytase and homologues

Details for Australian Patent Application No. 2005290934 (hide)

Owner Danisco A/S

Inventors Kumar, Vijay; Koltermann, Andre; Kettling, Ulrich; Pellangahr, Klaus; Miasnikov, Andrei; Leuthner, Birgitta; Kensch, Oliver

Agent Wrays

Pub. Number AU-B-2005290934

PCT Pub. Number WO2006/038128

Priority 0422052.1 04.10.04 GB; PCT/ 15.02.05 IB; IB2005/000598

Filing date 4 October 2005

Wipo publication date 13 April 2006

Acceptance publication date 23 December 2010

International Classifications

C12N 9/16 (2006.01) Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

A23K 1/165 (2006.01) Animal feeding-stuffs - with steroids, hormones, or enzymes

A23L 1/03 (2006.01) Foods or foodstuffs - containing additives

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/55 (2006.01) Mutation or genetic engineering - Hydrolases (3)

C12N 1/14 (2006.01) Micro-organisms, e.g. protozoa - Fungi

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12R 1/01 (2006.01)

Event Publications

5 April 2007 PCT application entered the National Phase

  PCT publication WO2006/038128 Priority application(s): WO2006/038128

23 December 2010 Application Accepted

  Published as AU-B-2005290934

21 April 2011 Standard Patent Sealed

5 July 2012 Alteration of Name

  The name of the patentee has been altered to DuPont Nutrition BioSciences ApS

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005290939-Label applicator system

2005290930-Subtype-matched inactivated whole virus vaccines for treating patients with HIV infection